Mizuho raised the firm’s price target on Alcon (ALC) to $120 from $115 and keeps an Outperform rating on the shares following the capital markets day. The company’s updated five-year long-range plan is well ahead of Street expectations, the analyst tells investors in a research note. The firm says Alcon’s portfolio is well hedged against regulatory and recession headwinds while numbers are “going notably higher.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Alcon’s Growth Prospects Boosted by Robust Product Pipeline and Market Opportunities: Buy Rating Affirmed
- Alcon acquires majority interest in Aurion Biotech
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Alcon upgraded to Buy from Neutral at BofA
- Alcon downgraded to Hold from Buy at HSBC